site stats

Gnpx offering

WebFeb 27, 2024 · Genprex, Inc. Announces $4 Million Registered Direct Offering With a Single, Healthcare-Focused Institutional Investor PR Newswire AUSTIN, Texas, Feb. 27, 2024 AUSTIN, Texas, Feb. 27, 2024 /PRNewsw... WebApr 6, 2024 · finance.yahoo.com - March 8 at 11:05 AM. Genprex, Inc. Announces $4 Million Registered Direct Offering With a Single, Healthcare-Focused Institutional Investor. finance.yahoo.com - February 27 at 9:05 PM. Genprex unveils groundbreaking data from primate study on its novel gene therapy to treat Type 1 diabetes at ATTD 2024 in Berlin.

What date does GENPREX

WebFeb 27, 2024 · Genprex Inc GNPX shares are trading lower by 19.12% to $1.10 during Monday's pre-market session. The company announced a $4 million registered direct offering with an institutional investor. WebFeb 23, 2024 · Our common stock is listed on The Nasdaq Capital Market under the symbol “GNPX.” On February 24, 2024, the last reported sale price of our common stock on The Nasdaq Capital Market was $1.36 per share. ... If you purchase securities in this offering, you may also experience future dilution as a result of future equity offerings. In order to ... gov statutory holidays https://hodgeantiques.com

GNPX Stock Price Genprex Inc. Stock Quote (U.S.: …

WebApr 12, 2024 · What is Genprex's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for Genprex stock is Buy based on the current 1 buy rating for GNPX. The average twelve-month price prediction for Genprex is $3.00 with a high price target of $3.00 and a low price target of $3.00. WebFeb 27, 2024 · The closing of the offering is expected to occur on or about March 1, 2024, subject to the satisfaction of customary closing conditions.The gross proceeds from the … WebDec 31, 2024 · Genprex, Inc. rapporteerde winstresultaten voor het volledige jaar eindigend op 31 december 2024. Voor het hele jaar rapporteerde het bedrijf een nettoverlies van 23,74 miljoen USD, vergeleken met... 13 april 2024 children\u0027s health food allergy

2024-02-27 NDAQ:GNPX Press Release Genprex Inc.

Category:GNPX Genprex, Inc. Stock Quote - FINVIZ.com

Tags:Gnpx offering

Gnpx offering

Breaking News: GNPX latest news. - The Fly

WebJan 3, 2024 · GNPX Stock: 5 Things to Know About Fast Track Designation. This is the second FTD that Genprex has received for REQORSA. The first FTD covers its use in combination with AstraZeneca’s (NASDAQ ... Web3/26/21. 11/12/20. 8/11/20. Showing 1 to 10 of 16 entries. Previous 1 2 Next. Show entries. Other Companies Releasing Earnings on the Same Day.

Gnpx offering

Did you know?

WebFeb 27, 2024 · The gross proceeds from the offering are expected to be approximately $4 million, before deducting placement agent fees and other estimated offering expenses. … WebGNPX: potential gap up tomorrow! huge amazing wedge!! this is the third time that price has made it to $4.25. GNPX has been rejected at this price twice before. Third time is winner …

WebMay 9, 2024 · The Genprex IPO faltered out of the gate. The company originally intended to price 2.5 million to 4.5 million shares in November 2024, which would have garnered gross proceeds of $12.5 million to ... WebApr 4, 2024 · AUSTIN, Texas, April 4, 2024 /PRNewswire/ -- Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing immunogene therapy for non-small cell lung cancer, announced today …

WebApr 4, 2024 · AUSTIN, Texas, April 4, 2024 /PRNewswire/ -- Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing immunogene therapy for non-small cell lung cancer, announced today the closing of its initial public offering on April 3, 2024 of an aggregate of 1,280,000 shares of common stock at a public offering … WebBased on 1 analyst offering 12 month price targets for Genprex Inc. Min Forecast. $3.00 +266.75%. Avg Forecast. $3.00 ... 0 analysts 0%. Strong Sell. 0 analysts 0%. Be the first to know when Wall Street analysts revise their GNPX stock forecasts and price targets. Get Free GNPX Updates. GNPX stock forecasts by analyst. All Analysts Top Analysts ...

WebGenprex Stock (NASDAQ: GNPX) stock price, news, charts, stock research, profile. ... Genprex, Inc. Announces $4 Million Registered Direct Offering With a Single, …

WebApr 13, 2024 · AUSTIN, Texas , March 23, 2024 /PRNewswire/ -- Rodney Varner , CEO of Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene … children\u0027s health foster care clinicWebJan 3, 2024 · Shares of Genprex Inc. GNPX, +2.29% skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast ... children\u0027s health foundation canadaWebFeb 27, 2024 · Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. … gov st marys rc j i \\u0026 n school wf17 8phWebApr 10, 2024 · Genprex, Inc. closed its IPO on April 3, 2024, selling 1.28 million shares of common stock at a price of $5.00 per share, and trades under the symbol "GNPX" … gov stay at homeWebApr 6, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNPX shares currently have a short interest ratio of 8.0. Learn More on Genprex's short interest ratio. gov stock forecastWebFeb 27, 2024 · GNPX Genprex Inc Genprex, Inc. Announces $4 Million Registered Direct Offering With a Single, Healthcare-Focused Institutional Investor Genprex, Inc. … gov stitt oklahoma contactWeb1 day ago · Genprex (GNPX) Receives a Buy from Noble Financial Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Genprex (GNPX - Research Report) today … gov stimulus checks